外周血淋巴细胞水平对血清CEA正常的结直肠癌患者的预后监测价值——淋巴细胞影响结直肠癌预后
Prognosis Value of Peripheral Lymphocytes Count in Colorectal Cancer Patients with Normal Serum CEA—Lymphocytes Predict Prognosis of Colorectal Cancer
DOI: 10.12677/ACM.2021.1111793, PDF,    国家自然科学基金支持
作者: 蔡雅诗:广州医科大学预防医学系,广东 广州;周敏仪:中山大学中山眼科中心国家重点实验室,广东 广州;王 佳, 鲁伟群, 沈西凌*, 黄志良*:广州医科大学附属肿瘤医院胃肠肿瘤外科,广东 广州
关键词: 结直肠癌癌胚抗原预后淋巴细胞血常规Colorectal Cancer CEA Prognosis Lymphocyte Blood Routine Indicators
摘要: 目的:探讨外周血常规指标对血清CEA水平正常的结直肠癌患者预后的监测价值。方法:收集广州医科大学附属肿瘤医院2015年1月至2018年12月收治的327例接受根治性手术的结直肠癌患者进行相关性和回归性分析。分析与血清CEA水平高低相关的临床资料,以及在血清CEA水平正常的结直肠癌患者中影响无复发生存期(Disease-free survival, DFS)的因素,筛选出血常规指标中该类患者临床预后有价值的监测指标。结果:血清CEA水平与结直肠癌患者的肿瘤分化程度(P = 0.047)、外周血中性粒细胞百分比(Neu%) (P = 0.022)、淋巴细胞百分比(Lym%) (P = 0.008)、淋巴细胞绝对值(Lym#) (P = 0.004)、中性粒细胞/淋巴细胞值(NLR) (P = 0.002)、淋巴细胞/单核细胞值(LMR) (P = 0.030)、血小板/淋巴细胞值(PLR) (P = 0.005)均有明显相关性。Logistic回归分析结果显示,外周血Lym# (P = 0.005)是血清CEA水平的独立影响因素(P < 0.05)。Cox回归分析结果显示,Lym# (P = 0.031)是影响血清CEA水平正常结直肠癌患者预后的独立因素(P < 0.05)。Lym# ≥ 1.805 × 109/L的患者DFS差于Lym < 1.805 × 109/L的患者(P = 0.016)。结论:外周血Lym#计数可用于评估血清CEA水平正常结直肠癌患者的临床预后。
Abstract: Objective: To investigate the prognosis value of routine blood indicators in colorectal cancer (CRC) patients with normal serum CEA level. Methods: A total of 327 patients with CRC and who received curative resection in the Affiliated Cancer Hospital of Guangzhou Medical University from January 2015 to December 2018 were analyzed by retrospective analysis. Relations of clinical data and different serum CEA levels were compared. Predictive factors of disease-free survival (DFS) in patients with normal serum CEA levels were analyzed, in order to select predictive marker(s) from routine blood test. Results: Serum CEA levels were revealed to relate to tumor differentiation (P = 0.047), percentage of peripheral neutrophils (Neu%) (P = 0.022), percentage of lymphocytes (Lym%) (P = 0.008), count of lymphocytes (Lym#) (P = 0.004), neutrophils to lymphocytes ratio (NLR) (P = 0.002), lymphocytes to monocytes ratio (LMR) (P = 0.030) and platelet to lymphocytes ratio (PLR) (P = 0.005). Logistic regression analysis showed Lym# was an independent impact factor of serum CEA level (P = 0.031). Cox regression analysis indicated that Lym# was an independent prognostic factor of DFS in patients with normal serum CEA level (P < 0.05). In the population of CRC with normal serum CEA, DFS of patients with Lym# ≥ 1.805 × 109/L was worse than that of patients with Lym# < 1.805 × 109/L (P = 0.016). Conclusions: Peripheral Lym# can be a useful prognostic predictor of CRC patients with normal serum CEA level.
文章引用:蔡雅诗, 周敏仪, 王佳, 鲁伟群, 沈西凌, 黄志良. 外周血淋巴细胞水平对血清CEA正常的结直肠癌患者的预后监测价值——淋巴细胞影响结直肠癌预后[J]. 临床医学进展, 2021, 11(11): 5364-5372. https://doi.org/10.12677/ACM.2021.1111793

参考文献

[1] 兰蓝, 赵飞, 蔡玥, 武瑞仙, 孟群. 中国居民2015年恶性肿瘤死亡率流行病学特征分析[J]. 中华流行病学杂志, 2018, 39(1): 32-34.
[2] Hao, C., Zhang, G. and Zhang, L. (2019) Serum CEA Levels in 49 Different Types of Cancer and Noncancer Diseases. Progress in Molecular Biology and Translational Science, 162, 213-227.
[Google Scholar] [CrossRef] [PubMed]
[3] 李会平, 代爱军. 结直肠癌患者术前血清癌胚抗原及糖类抗原19-9阳性与临床病理学特征的关系[J]. 中国肛肠病杂志, 2019, 39(1): 1-3.
[4] Huang, Z.L., Luo, J., Chen, M.S., Li, J.Q. and Shi, M. (2011) Blood Neutrophil-to-Lymphocyte Ratio Predicts Survival in Patients with Unresectable Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization. Journal of Vascular and Interventional Radiology, 22, 702-709.
[Google Scholar] [CrossRef] [PubMed]
[5] 周婷, 吴克俭. 中性粒细胞/淋巴细胞、血小板/淋巴细胞和纤维蛋白原在结直肠癌中的预测作用[J]. 医学研究杂志, 2019, 48(8): 154-157.
[6] 彭维忠, 杨浩洁, 张克兰, 秧茂盛. 术前外周血NLR和PLR在结直肠癌预后评估中的价值[J]. 中国免疫学杂志, 2019, 35(4): 471-475.
[7] 姚青林, 王景杰, 李欢, 王成, 赵曙光. 中性粒细胞/淋巴细胞比率、C反应蛋白/白蛋白比率、血小板/淋巴细胞比率与结直肠癌患者预后的关系[J]. 疑难病杂志, 2020, 19(6): 595-598+616.
[8] Tanio, A., Saito, H., Uejima, C., et al. (2019) A Prognostic Index for Colorectal Cancer Based on Preoperative Absolute Lymphocyte, Monocyte, and Neutrophil Counts. Surgery Today, 49, 245-253.
[Google Scholar] [CrossRef] [PubMed]
[9] 崔美琦, 杨涛, 徐睿, 杨彤欣, 薛天慧, 颜兵. 术前单核细胞计数对海南省结直肠癌患者预后的预测价值分析[J]. 癌症进展, 2020, 18(11): 1155-1158+1162.
[10] Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
[Google Scholar] [CrossRef] [PubMed]
[11] Grivennikov, S.I., Greten, F.R. and Karin, M. (2010) Immunity, Inflammation, and Cancer. Cell, 140, 883-899.
[Google Scholar] [CrossRef] [PubMed]
[12] Zhang, J., et al. (2017) The Elevated NLR, PLR and PLT May Predict the Prognosis of Patients with Colorectal Cancer: A Systematic Review and Meta-Analysis. Oncotarget, 8, 68837-68846.
[Google Scholar] [CrossRef] [PubMed]
[13] 王琰, 卢斌峰, 蒋敬庭. 肿瘤浸润淋巴细胞及其亚群在肿瘤免疫中的作用[J]. 临床检验杂志, 2018, 36(11): 854-857.
[14] Kitayama, J., Yasuda, K., Kawai, K., Sunami, E. and Nagawa, H. (2010) Circulating Lymphocyte Number Has a Positive Association with Tumor Response in Neoadjuvant Chemoradiotherapy for Advanced Rectal Cancer. Radiation Oncology, 5, 47.
[Google Scholar] [CrossRef